Mia Grisco, Person With Narcolepsy, on the FDA Approval of LUMRYZ for Pediatric Patients

Mia Grisco, a brave young person living with narcolepsy, shared her perspective on the FDA’s recent approval of Avadel’s LUMRYZ for the treatment of cataplexy or excessive daytime sleepiness (EDS) in pediatric patients. Mia describe the main benefits she’s experienced since going on LUMRYZ, and provided a message to health care providers who can now treat younger patients with this game-changing therapy.